Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Canadian cannabis edibles producer Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF) reported on Tuesday its second quarter financial results for the three months ending June 30, 2023.
"This was a transitional and busy quarter for Indiva, with several cross-currents impacting our results, including the negative impact from the loss of revenue from our Indiva Life Lozenges and partial revenue loss in the quarter from the transition to contract manufacturing of Wana gummies, offset by continued growth and excellent market share gains from Pearls by Grön gummies," Niel Marotta, president and CEO of Indiva, said.
Marotta was a guest speaker at Benzinga Cannabis Capital Conference in April 2021. The event returns to Chicago this September and will feature a slew of top cannabis CEOs, executives, entrepreneurs and lawmakers in the space.
"While we maintain that the Lozenge products were compliant with the Cannabis Act and had the positive effect of migrating dollars from the illicit market to the legal market, we complied with regulatory orders and discontinued production and packaging of these products in March 2023, and completed all sales of finished goods to provincial wholesalers in May 2023," Marotta continued.
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo: Courtesy of Hvoenok and GOR Photo on Shutterstock